Cite
MLA Citation
M T Abreu et al.. “DOP83 Efficacy and Safety of Ustekinumab for Ulcerative Colitis Through 3 Years: UNIFI Long-term Extension.” Journal of Crohn's and colitis, vol. 15, n.d., pp. S113–S115. http://access.bl.uk/ark:/81055/vdc_100130765034.0x00001d